SAR245408
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SAR245408, covering 2014-06-13 to 2019-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen [Phase 1, Phase 2]